Illumina is a global leader in genomics and precision health, advancing how researchers, clinicians, and healthcare organizations understand human biology through DNA sequencing and array-based technologies. Founded in 1998 and based in San Diego, Illumina has accelerated genomic discovery and expanded access to precision medicine worldwide. Its platforms drive progress in oncology, reproductive health, genetic disease research, infectious disease detection, and population genomics, enabling more personalized and effective healthcare. Operating in over 165 countries and committed to scientific collaboration, Illumina focuses on accessibility, accuracy, and scalability. Guided by a vision to unlock the power of the genome for humanity, the company is dedicated to improving global health through innovation and transformative technologies.